Cargando…
Entrectinib‐induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1‐rearranged non‐small cell lung cancer
A 75‐year‐old woman was referred to our hospital because of a productive cough and an abnormal shadow on chest radiography. She was diagnosed as having metastatic lung adenocarcinoma harbouring ROS proto‐oncogene 1 (ROS1). First‐line therapy was instituted with entrectinib 600 mg daily, and a gradua...
Autores principales: | Kato, Chiaki, Sekiya, Muneyuki, Sekiguchi, Ryo, Yamasaki, Akira, Yoshizawa, Takahiro, Isobe, Kazutoshi, Tochigi, Naobumi, Shibuya, Kazutoshi, Kishi, Kazuma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507430/ https://www.ncbi.nlm.nih.gov/pubmed/37731587 http://dx.doi.org/10.1002/rcr2.1217 |
Ejemplares similares
-
Successful treatment with inhaled corticosteroid/long-acting β(2)-agonist in a case of allergic bronchopulmonary mycosis caused by Schizophyllumcommune
por: Sekiya, Muneyuki, et al.
Publicado: (2023) -
Giant thymoma successfully resected via anterolateral thoracotomy: a case report
por: Saito, Takahiro, et al.
Publicado: (2015) -
Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression
por: Isshiki, Takuma, et al.
Publicado: (2018) -
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2019) -
Upregulation of long non‑coding RNA LINC00460 in EGFR‑mutant lung cancer indicates a poor prognosis in patients treated with osimertinib
por: Nakano, Yuta, et al.
Publicado: (2023)